QSIM- now set up for an explosive month
From the 10k one could easily foretell what was going to happen with the share count.
On February 2, 2017, the Company issued a convertible note for $68,000 (see Subsequent Events). The Company currently has sufficient cash for operations through February 2017. The Company will pursue the issuance of notes payable to provide cash for operations through either March 2017 or April 2017. Such cash will allow the Company to continue to pursue additional equity financing based on the receipt of a purchase order from an ammonia plant and/or additional debt financing alternatives. In addition, although a formal plan has not been adopted to do so, the Company is exploring possible opportunities to sell its assets pursuant to an asset purchase agreement. In this regard, the Company has had preliminary discussions with multiple parties that have expressed an interest in acquiring the Company’s assets.
Now look at this PR from 10 days later and during the three largest volume days at $QSIM
Quote:
As of today, QuantumSphere has 10 issued patents.
The Company entered into a multi-year Commercialization Partnership Agreement with Swiss-based Casale S.A. (Casale), pursuant to which the parties agreed to the terms of commercialization of the Company's QSI-Nano iron catalysts for ammonia synthesis. Casale is restricted from entering into any agreement with any third party for any purpose relating to the use of nano-sized particle based catalysts in ammonia synthesis. Further, during the term, Casale has exclusive rights to commercially market, co-brand and sell the FeNIX product into the ammonia market globally, with the exception of China. The Company is now in the initial commercialization phase with its partner Casale in addressing the market opportunity within the $100 billion annual ammonia market. Per its commercialization agreement, Casale is responsible for the sales and marketing efforts of FeNIX to its existing and prospective customers.
AND EVEN MORE IMPRESSIVELY... Even though one would have expected the stock price to go down from the .005's landing area thr past month....
QuantumSphere is currently in sales discussions with multiple ammonia plant operators. A particular focus is on India due to their compelling need and the size of the market (India is the #2 world producer of ammonia after China). "QuantumSphere has generated considerable excitement in India this past year, where the increased output and energy savings that its FeNIX product can provide are particularly critical," says Bill Collins, Executive Vice President of GRMC, QSI's representative company in India. "QSI was a featured presenter at India's most prestigious fertilizer conference and has caught the attention of the "who's who" of the Indian chemical industry."
The recent stock activity in QuantumSphere, which has witnessed a dramatic decline in price and significant increase in volume, is a result of debt converting to equity. While it caused a major drop in stock price, the debt conversions have improved the company's balance sheet. The Company may experience further conversions of debt to equity in the near future. Investors are encouraged to carefully review QuantumSphere's latest 10-Q filing for details. In this regard, the Company is exploring opportunities related to additional financings, licensing of its technology, and a possible sale of assets pursuant to an asset purchase agreement. The Company has had preliminary discussions with multiple parties that have expressed an interest in additional debt financing or acquiring company assets.
THAT LAST PART of the PR sure sounds very intriguing! Seems like the company is not only actively trying to place their patented product directly into Ammonia plants in 2017, but they already have an exclusive sales and commercializations partnership with an incredible Swiss company Casale S.A.
One might be asking, what is all this excitement then about with the stock testing .012's and falling back to .007's and then testing .011's and falling back to .0098? The answer is quite simple. The company issued 127mil shares up to Feb 17th and we have witnessed all of those hitting the market. On top of that, we witnessed about 150mil more shares absorbed over the last three sessions March 1- March 3rd whereby significantly cleaning up this balance sheet and making it look much more attractive for a Asset purchase agreement OR even a partnership with a very successful capital company that will stop all topic and convertible loans such as referenced here from the latest 10K.
Therefore, it is my opinion, that we are the precipice here of some big news in March of an agreement for commercializations and sales at a key ammonia plant as per the recent press release and all steps are being taken to clean up the books. The stock pricing increasing during this period of major dilution is indicative of the markets interest in this company's 10 Patents for nanocatalysts and it's already absorbing ion of the first 127mil shares into the market. There is not much more left to convert now as Maloney engages SALES to 2 ammonia plants now. The minute one deal goes forward - QSIM has two huge suitors, in Avalon and US Capital Partners who would buy out Preferred shares, ending all toxic needs and then providing the cash flow of $5mil for operations now that QSIM secured one of those deals with Casale help.
From the 10Q issue in mid Feb--2017
Quote:
From January 1, 2017 through February 17, 2017, $599,620 in June 8, 2016 promissory notes and related interest that were in default have been converted into 127,484,915 shares of common stock. The Company anticipates that additional outstanding debt will be converted into common shares from available authorized common stock.
The Company engaged U.S. Capital Partners and Avalon Securities for a proposed issuance of up to $5.0 million of 8% Series A convertible preferred stock. The Company completed the due diligence phase and both firms presented the offering to potential accredited investors. At this time, potential accredited investors have indicated that they will await the issuance of a purchase order for the Company’s nano iron from an ammonia plant before considering investing in the Company’s 8% Series A convertible preferred stock.
From the 10k one could easily foretell what was going to happen with the share count.
On February 2, 2017, the Company issued a convertible note for $68,000 (see Subsequent Events). The Company currently has sufficient cash for operations through February 2017. The Company will pursue the issuance of notes payable to provide cash for operations through either March 2017 or April 2017. Such cash will allow the Company to continue to pursue additional equity financing based on the receipt of a purchase order from an ammonia plant and/or additional debt financing alternatives. In addition, although a formal plan has not been adopted to do so, the Company is exploring possible opportunities to sell its assets pursuant to an asset purchase agreement. In this regard, the Company has had preliminary discussions with multiple parties that have expressed an interest in acquiring the Company’s assets.
Now look at this PR from 10 days later and during the three largest volume days at $QSIM
Quote:
As of today, QuantumSphere has 10 issued patents.
The Company entered into a multi-year Commercialization Partnership Agreement with Swiss-based Casale S.A. (Casale), pursuant to which the parties agreed to the terms of commercialization of the Company's QSI-Nano iron catalysts for ammonia synthesis. Casale is restricted from entering into any agreement with any third party for any purpose relating to the use of nano-sized particle based catalysts in ammonia synthesis. Further, during the term, Casale has exclusive rights to commercially market, co-brand and sell the FeNIX product into the ammonia market globally, with the exception of China. The Company is now in the initial commercialization phase with its partner Casale in addressing the market opportunity within the $100 billion annual ammonia market. Per its commercialization agreement, Casale is responsible for the sales and marketing efforts of FeNIX to its existing and prospective customers.
AND EVEN MORE IMPRESSIVELY... Even though one would have expected the stock price to go down from the .005's landing area thr past month....
QuantumSphere is currently in sales discussions with multiple ammonia plant operators. A particular focus is on India due to their compelling need and the size of the market (India is the #2 world producer of ammonia after China). "QuantumSphere has generated considerable excitement in India this past year, where the increased output and energy savings that its FeNIX product can provide are particularly critical," says Bill Collins, Executive Vice President of GRMC, QSI's representative company in India. "QSI was a featured presenter at India's most prestigious fertilizer conference and has caught the attention of the "who's who" of the Indian chemical industry."
The recent stock activity in QuantumSphere, which has witnessed a dramatic decline in price and significant increase in volume, is a result of debt converting to equity. While it caused a major drop in stock price, the debt conversions have improved the company's balance sheet. The Company may experience further conversions of debt to equity in the near future. Investors are encouraged to carefully review QuantumSphere's latest 10-Q filing for details. In this regard, the Company is exploring opportunities related to additional financings, licensing of its technology, and a possible sale of assets pursuant to an asset purchase agreement. The Company has had preliminary discussions with multiple parties that have expressed an interest in additional debt financing or acquiring company assets.
THAT LAST PART of the PR sure sounds very intriguing! Seems like the company is not only actively trying to place their patented product directly into Ammonia plants in 2017, but they already have an exclusive sales and commercializations partnership with an incredible Swiss company Casale S.A.
One might be asking, what is all this excitement then about with the stock testing .012's and falling back to .007's and then testing .011's and falling back to .0098? The answer is quite simple. The company issued 127mil shares up to Feb 17th and we have witnessed all of those hitting the market. On top of that, we witnessed about 150mil more shares absorbed over the last three sessions March 1- March 3rd whereby significantly cleaning up this balance sheet and making it look much more attractive for a Asset purchase agreement OR even a partnership with a very successful capital company that will stop all topic and convertible loans such as referenced here from the latest 10K.
Therefore, it is my opinion, that we are the precipice here of some big news in March of an agreement for commercializations and sales at a key ammonia plant as per the recent press release and all steps are being taken to clean up the books. The stock pricing increasing during this period of major dilution is indicative of the markets interest in this company's 10 Patents for nanocatalysts and it's already absorbing ion of the first 127mil shares into the market. There is not much more left to convert now as Maloney engages SALES to 2 ammonia plants now. The minute one deal goes forward - QSIM has two huge suitors, in Avalon and US Capital Partners who would buy out Preferred shares, ending all toxic needs and then providing the cash flow of $5mil for operations now that QSIM secured one of those deals with Casale help.
From the 10Q issue in mid Feb--2017
Quote:
From January 1, 2017 through February 17, 2017, $599,620 in June 8, 2016 promissory notes and related interest that were in default have been converted into 127,484,915 shares of common stock. The Company anticipates that additional outstanding debt will be converted into common shares from available authorized common stock.
The Company engaged U.S. Capital Partners and Avalon Securities for a proposed issuance of up to $5.0 million of 8% Series A convertible preferred stock. The Company completed the due diligence phase and both firms presented the offering to potential accredited investors. At this time, potential accredited investors have indicated that they will await the issuance of a purchase order for the Company’s nano iron from an ammonia plant before considering investing in the Company’s 8% Series A convertible preferred stock.
1
